https://lucyrx.com/wp-content/uploads/2026/05/featured-image-1.png
536
800
Kyrstin Hensley
/wp-content/uploads/2025/03/LucyRx-Logo-Primary.svg
Kyrstin Hensley2026-05-28 23:27:512026-06-18 10:11:55The Human Side of Pharmacy SavingsGuides & Toolkits

Six employer-tested PBM strategies for controlling pharmacy cost, improving transparency, and delivering better member outcomes in 2026.
GLP-1 growth, specialty drug spend, and opaque PBM practices are forcing employers to rethink how pharmacy is governed, not just how it is priced.
6 for 2026 shares six real employer and member scenarios that show how organizations are managing:
- GLP-1 utilization and cost exposure
- Specialty drug growth
- Biosimilar adoption
- Women’s health and menopause care
- PBM transparency and accountability
Each scenario highlights the challenge, the strategy shift, and the impact on cost, access, and member experience, so you can quickly see what actually works in today’s pharmacy landscape.
Want a clearer view of your pharmacy benefit?
LucyRx works with employers, brokers, and consultants to apply these prescription care strategies to real pharmacy data, helping leaders understand where cost, access, and outcomes are aligned, and where they are not.
Recommended Reads
https://lucyrx.com/wp-content/uploads/2026/05/featured-image-1.png
536
800
Kyrstin Hensley
/wp-content/uploads/2025/03/LucyRx-Logo-Primary.svg
Kyrstin Hensley2026-05-28 23:27:512026-06-18 10:11:55The Human Side of Pharmacy Savings
Pharmacy Savings Shouldn’t Come at the Employee’s Expense
Pharmacy savings shouldn't come at the employee's expense. See how one large hospitality and entertainment employer reduced net pharmacy spend by 15% in year one while lowering member PMPM from $16.10 to $9.52, through focused GLP-1 management, Care Guide support, and a smart biosimilar strategy.

Women’s Heart Health Belongs in the Benefits Conversation
Benefit conversations still tend to treat menopause, heart health, weight, diabetes, pharmacy coverage, and care navigation as separate issues. They are not separate for the woman trying to navigate them.

The CFO Case for Care Guides: From Cost Pressure to Controllable Results
Care Guides lower specialty spend and improve adherence. Discover how employers can reduce PMPM costs and gain measurable ROI.
Access Is the First Outcome
Pharmacy access is the first outcome of a pharmacy benefit. When employees can’t reach their medication, adherence, productivity, and trust break down quickly.
PBM Reform Update: What the CAA and DOL Proposal Mean for Plan Sponsors
With the Consolidated Appropriations Act of 2026 and a Department of Labor proposal focused on PBM disclosures, employers are seeing more headlines and asking sharper questions about how their pharmacy benefits are structured.
Making Menopause Support Real: What Employers Are Asking and How We Help
Menopause affects retention, productivity, and healthcare costs. Learn why employers are making menopause support a core benefits strategy.
Menopause Is a Workforce Issue. Your Pharmacy Benefit Should Treat It That Way.
Menopause affects productivity, retention, and healthcare costs. Learn why pharmacy benefit design is central to effective menopause support.

Menopause Benefits: From Nice-to-Have to Business Imperative
Menopause affects retention, productivity, and healthcare costs. Learn why employers are making menopause support a core benefits strategy.
Why “Affordability” Became the Word of the Moment — and What Healthcare Misses
Healthcare affordability is not just about price. Learn what patients experience at the pharmacy counter and why unpredictability erodes trust.

The Human Side of Pharmacy Savings
Savings matter. The person behind each case matters more. How LucyRx Care Guides delivered $2.37 million in savings by starting with one simple thing: listening.

Pharmacy Savings Shouldn’t Come at the Employee’s Expense
Pharmacy savings shouldn't come at the employee's expense. See how one large hospitality and entertainment employer reduced net pharmacy spend by 15% in year one while lowering member PMPM from $16.10 to $9.52, through focused GLP-1 management, Care Guide support, and a smart biosimilar strategy.

Women’s Heart Health Belongs in the Benefits Conversation
Benefit conversations still tend to treat menopause, heart health, weight, diabetes, pharmacy coverage, and care navigation as separate issues. They are not separate for the woman trying to navigate them.

The CFO Case for Care Guides: From Cost Pressure to Controllable Results
Care Guides lower specialty spend and improve adherence. Discover how employers can reduce PMPM costs and gain measurable ROI.
Access Is the First Outcome
Pharmacy access is the first outcome of a pharmacy benefit. When employees can’t reach their medication, adherence, productivity, and trust break down quickly.
PBM Reform Update: What the CAA and DOL Proposal Mean for Plan Sponsors
With the Consolidated Appropriations Act of 2026 and a Department of Labor proposal focused on PBM disclosures, employers are seeing more headlines and asking sharper questions about how their pharmacy benefits are structured.
Making Menopause Support Real: What Employers Are Asking and How We Help
Menopause affects retention, productivity, and healthcare costs. Learn why employers are making menopause support a core benefits strategy.
Menopause Is a Workforce Issue. Your Pharmacy Benefit Should Treat It That Way.
Menopause affects productivity, retention, and healthcare costs. Learn why pharmacy benefit design is central to effective menopause support.

Menopause Benefits: From Nice-to-Have to Business Imperative
Menopause affects retention, productivity, and healthcare costs. Learn why employers are making menopause support a core benefits strategy.

Share